| 1 |
17692293 | A promoter polymorphism in the monoamine oxidase A gene is associated with the pineal MAOA activity in Alzheimer's disease patients. | 2007 Sep 5 |
1 |
| 2 |
16944667 | Genetically increased risk of sleep disruption in Alzheimer's disease. | 2006 Aug |
1 |
| 3 |
14671188 | Molecular changes underlying reduced pineal melatonin levels in Alzheimer disease: alterations in preclinical and clinical stages. | 2003 Dec |
2 |
| 4 |
7931233 | The effect of 6-months l-deprenyl administration on pineal MAO-A and MAO-B activity and on the content of melatonin and related indoles in aged female Fisher 344N rats. | 1994 |
1 |
| 5 |
2099892 | Neuropharmacology of pineal secretions. | 1990 |
1 |
| 6 |
3363166 | Effect of brofaromine and pargyline on human plasma melatonin concentrations. | 1988 |
1 |
| 7 |
2875125 | Effects of antidepressants and other psychotropic drugs on melatonin release and pineal gland function. | 1986 |
2 |
| 8 |
3008207 | Human plasma melatonin is elevated during treatment with the monoamine oxidase inhibitors clorgyline and tranylcypromine but not deprenyl. | 1986 Feb |
2 |
| 9 |
2412565 | Effect of superior cervical ganglionectomy on melatonin stimulation by specific MAO-A inhibition. | 1985 Sep 15 |
1 |